Compounded GLP-1 medicines usually contain pharmacy-prepared semaglutide or tirzepatide. They are not FDA-approved. This guide explains the 2026 regulatory context, product-label questions and safety checks to discuss before treatment.
GLP-1 medicines affect appetite, fullness and blood sugar. Some also slow stomach emptying. Tirzepatide acts on GIP as well as GLP-1 receptors. The exact product determines its approved uses, instructions and risks.
Nausea, constipation, diarrhea and vomiting are common GLP-1 side effects. Severe symptoms need review. This guide separates common reactions from urgent signs and explains FDA’s 2026 warning update.
A medical weight loss evaluation reviews your weight history, health, medicines and previous attempts. The physician may check BMI, blood pressure and lab results, then discuss treatment and follow-up options.
